STING1 and autoimmune disease: The endogenous agonistic ligand cGAMP, exogenous small-molecule agonists (diABZI, ref. 55; DMXAA, ref. 56, etc.), and a variety of autoimmune disease–associated, self-activating mutations (57) all exert their biologic effects through induction or stabilization of STING oligomerization.